Filing Details
- Accession Number:
- 0001225208-15-022473
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-16 12:37:10
- Reporting Period:
- 2015-12-14
- Filing Date:
- 2015-12-16
- Accepted Time:
- 2015-12-16 12:37:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1463423 | C Jim Beasley | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-14 | 8,656 | $84.58 | 32,969 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-14 | 5,977 | $97.69 | 38,946 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-14 | 5,944 | $136.37 | 44,890 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-14 | 2,200 | $183.34 | 42,690 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-14 | 2,227 | $186.09 | 40,463 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-14 | 6,781 | $184.30 | 33,682 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-14 | 9,369 | $185.14 | 24,313 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2015-12-14 | 5,944 | $0.00 | 5,944 | $136.37 |
| Common Stock | Option (Right to Buy) | Disposition | 2015-12-14 | 5,977 | $0.00 | 5,977 | $97.69 |
| Common Stock | Option (Right to Buy) | Disposition | 2015-12-14 | 8,656 | $0.00 | 8,656 | $84.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,888 | 2023-12-11 | No | 4 | M | Direct | |
| 5,978 | 2022-12-12 | No | 4 | M | Direct | |
| 0 | 2021-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,101 | Indirect | 401(k) Plan |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $182.79 to $183.77. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $185.92 to $186.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $183.90 to $184.86. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $184.90 to $185.8621. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Includes 5.637 shares acquired under the Company's 401(k) Plan from May 9, 2015 to November 6, 2015.
- Options granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant 5,944 options vested on December 11, 2015 and the remaining options vest in two annual installments beginning on December 11, 2016.
- Of this option grant 5,977 options vested on December 12, 2015 and the remaning options will vest on December 12, 2016.
- Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Option fully vested on December 14, 2015.
Billionaire Hedge Funds
